share_log

Brookline Capital Initiates Coverage On Immunic With Buy Rating, Announces Price Target of $10

Brookline Capital Initiates Coverage On Immunic With Buy Rating, Announces Price Target of $10

布鲁克林资本以买入评级启动对Immunic的报道,宣布目标股价为10美元
Moomoo 24/7 ·  04/05 04:59

Brookline Capital analyst Tyler Bussian initiates coverage on Immunic (NASDAQ:IMUX) with a Buy rating and announces Price Target of $10.

布鲁克林资本分析师泰勒·布西安以买入评级启动了对Immunic(纳斯达克股票代码:IMUX)的报道,并宣布目标股价为10美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发